N
EVH icon

Nuveen’s Evolent Health EVH Stock Holding History

Nuveen’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Sell
265,142
-76,067
-22% -$241K ﹤0.01% 2770
2025
Q4 		$1.36M Buy
341,209
+82,550
+32% +$459K ﹤0.01% 2458
2025
Q3 		$2.19M Hold
258,659
– – ﹤0.01% 2268
2025
Q2 		$2.91M Sell
258,659
-396,805
-61% -$3.64M ﹤0.01% 2128
2025
Q1 		$6.21M Buy
655,464
+5,204
+0.8% +$52.6K ﹤0.01% 1810
2024
Q4 		$7.32M Sell
650,260
-43,974
-6% -$773K ﹤0.01% 1771
2024
Q3 		$19.6M Buy
694,234
+390,763
+129% +$10.1M 0.01% 1210
2024
Q2 		$5.8M Sell
303,471
-64,522
-18% -$1.65M ﹤0.01% 1872
2024
Q1 		$12.1M Sell
367,993
-24,144
-6% -$770K ﹤0.01% 1486
2023
Q4 		$13M Sell
392,137
-12,525
-3% -$354K ﹤0.01% 1422
2023
Q3 		$11M Sell
404,662
-328,477
-45% -$9.13M ﹤0.01% 1419
2023
Q2 		$22.2M Sell
733,139
-505,997
-41% -$16.4M 0.01% 1008
2023
Q1 		$40.2M Buy
1,239,136
+574,160
+86% +$18.2M 0.01% 650
2022
Q4 		$18.7M Sell
664,976
-471,809
-42% -$13.5M 0.01% 1088
2022
Q3 		$40.8M Buy
1,136,785
+100,206
+10% +$3.53M 0.02% 611
2022
Q2 		$31.8M Buy
1,036,579
+46,204
+5% +$1.35M 0.01% 757
2022
Q1 		$31.1M Buy
990,375
+24,664
+3% +$646K 0.01% 899
2021
Q4 		$25.4M Buy
965,711
+133,382
+16% +$3.83M 0.01% 1074
2021
Q3 		$22M Sell
832,329
-27,059
-3% -$650K 0.01% 1203
2021
Q2 		$18.2M Sell
859,388
-105,311
-11% -$2.11M 0.01% 1444
2021
Q1 		$19.5M Sell
964,699
-16,135
-2% -$307K 0.01% 1341
2020
Q4 		$15.7M Buy
980,834
+15,507
+2% +$205K 0.01% 1402
2020
Q3 		$12M Buy
965,327
+504,392
+109% +$5.93M ﹤0.01% 1399
2020
Q2 		$3.28M Buy
460,935
+73,865
+19% +$495K ﹤0.01% 2115
2020
Q1 		$2.1M Sell
387,070
-15,720
-4% -$140K ﹤0.01% 2160
2019
Q4 		$3.65M Buy
402,790
+4,147
+1% +$33.7K ﹤0.01% 2148
2019
Q3 		$2.87M Buy
398,643
+16,994
+4% +$122K ﹤0.01% 2242
2019
Q2 		$3.03M Buy
+381,649
New +$4.52M ﹤0.01% 2242
2017
Q4 		– Sell
-41,787
Closed -$744K – 1105
2017
Q3 		$744K Sell
41,787
-9,549
-19% -$197K ﹤0.01% 832
2017
Q2 		$1.3M Buy
+51,336
New +$1.23M 0.01% 693

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's EVH Position: Q1 2026 in Review

Nuveen reduced its Evolent Health (EVH) stake by 22% in Q1 2026, selling an estimated $241K and leaving 265,142 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

Nuveen first reported a position in EVH in Q2 2017 and has held it in 30 quarters since. The position peaked at $40.8M in Q3 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Nuveen held 265,142 shares of Evolent Health worth $605K as of Q1 2026.
  • Nuveen sold 76,067 Evolent Health shares in Q1 2026, an estimated $241K.
  • Evolent Health made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2770 holding.
  • Nuveen first reported a position in Evolent Health in Q2 2017 and has held it in 30 quarters since.
  • Nuveen's Evolent Health position peaked at $40.8M in Q3 2022.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.